Staidson (Beijing) BioPharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Staidson (Beijing) BioPharmaceuticals has a total shareholder equity of CN¥1.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.3B and CN¥251.2M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥42.73m |
| Equity | CN¥1.03b |
| Total liabilities | CN¥251.22m |
| Total assets | CN¥1.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300204's short term assets (CN¥189.1M) exceed its short term liabilities (CN¥172.5M).
Long Term Liabilities: 300204's short term assets (CN¥189.1M) exceed its long term liabilities (CN¥78.7M).
Debt to Equity History and Analysis
Debt Level: 300204 is debt free.
Reducing Debt: 300204 had no debt 5 years ago.
Debt Coverage: 300204 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300204 has no debt, therefore coverage of interest payments is not a concern.